Aminomethylamide

Aminomethylamide

SCHEMBL5692113

Cc1cc(-c2nc3cc(F)ccc3s2)ccc1N.NCC(N)=O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.53
NPC1 O15118 4/20 0.47
NFKB1 P19838 4/20 0.47
RAB9A P51151 4/20 0.47
NFKB2 Q00653 4/20 0.47
RELA Q04206 4/20 0.47
HPGD P15428 2/20 0.47
STAT1 P42224 1/20 0.47
DYRK1A Q13627 3/20 0.47
ILK Q13418 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
APP P05067 6/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43
TP53 P04637 1/20 0.43
KDM4E B2RXH2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aminomethylamide SCHEMBL5692730 0.99 AHR (0.52) AHRNPC1NFKB1RAB9ANFKB2
SCHEMBL30966554 0.89 AHR (0.60) AHRNPC1NFKB1RAB9ANFKB2
SCHEMBL30365100 0.89 AHR (0.60) AHRNPC1NFKB1RAB9ANFKB2
SCHEMBL3050082 0.89 AHR (0.60) AHRNPC1NFKB1RAB9ANFKB2
SCHEMBL5692717 0.88 AHR (0.52) AHRNPC1NFKB1RAB9ANFKB2
Hydrochloric Acid SCHEMBL5691360 0.87 AHR (0.51) AHRNPC1NFKB1RAB9ANFKB2
Alanine SCHEMBL5691734 0.86 AHR (0.49) AHRNPC1NFKB1RAB9ANFKB2
SCHEMBL5692785 0.84 AHR (0.44) AHRNPC1NFKB1RAB9ANFKB2
Hydrochloric Acid SCHEMBL5691320 0.84 AHR (0.44) AHRNPC1NFKB1RAB9ANFKB2
SCHEMBL5691118 0.80 APP (0.68) NPC1RAB9AILKAPPMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1204650-B1 SUBSTITUTED 2-ARYLBENZAZOLE COMPOUNDS AND THEIR USE AS ANTITUMOUR AGENTS CANCER RES VENTURES LTD (GB) 2006-04-19 EP claimed